Gabapentin and Mirvaso drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Mirvaso (brimonidine tartrate). Common drug interactions include pyrexia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Mirvaso. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

What is Mirvaso?

Mirvaso has active ingredients of brimonidine tartrate. eHealthMe is studying from 1,541 Mirvaso users. Check the latest studies of Mirvaso.



On Jul, 20, 2026

16 people who take Gabapentin and Mirvaso together, and have interactions are studied.

Gabapentin and Mirvaso drug interactions.

What are the common drug interactions of Gabapentin and Mirvaso, by gender? *:

female:

  1. Pyrexia (fever)
  2. Eyelid oedema (eyelids are swollen and contain excessive fluid)
  3. Hypersensitivity
  4. Overdose
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Rash erythematous (redness of the skin)
  7. Rash macular (small, flat red spots)
  8. Scab (a hard coating on the skin formed during the wound healing)
  9. Skin depigmentation (lightening of the skin)
  10. Skin exfoliation (removal of the oldest dead skin cells)

male:

  1. Fatigue (feeling of tiredness)
  2. Muscle twitching

What are the common drug interactions of Gabapentin and Mirvaso, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain upper
  2. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  3. Colitis ulcerative (inflammation of colon with ulcer)
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Diarrhoea
  6. Disability
  7. Dyspepsia (indigestion)
  8. Erythema (redness of the skin)
  9. Gastrointestinal pain
  10. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

50-59:

n/a

60+:

  1. Diarrhoea
  2. Acute respiratory failure
  3. Hypoxia (low oxygen in tissues)
  4. Insomnia (sleeplessness)
  5. Pneumonia
  6. Pyrexia (fever)
  7. Renal disorder (kidney disease)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Skin burning sensation
  10. Urinary tract infection

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 4 people, 25.00%
  2. Rosacea (a skin condition that causes facial redness): 3 people, 18.75%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 12.50%
  4. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 12.50%
  5. Gait Disturbance: 2 people, 12.50%
  6. Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 12.50%
  7. Neuropathy Peripheral (surface nerve damage): 1 person, 6.25%
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 6.25%
  9. Pain In Extremity: 1 person, 6.25%
  10. Psoriasis (immune-mediated disease that affects the skin): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Mirvaso?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gabapentin and Mirvaso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mirvaso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mirvaso and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and brimonidine tartrate (the active ingredients of Gabapentin and Mirvaso, respectively), and Gabapentin and Mirvaso (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: